ASPIRE-Med项目:澳大利亚针对残疾人支持工作人员的心理药物培训计划的研究协议
Macey Barratt1,2, Kathryn Speer3,2, Shoumitro Deb4
1Centre for Ageing Research and Translation, University of Canberra, Bruce, Australian Capital Territory, Australia Macey.Barratt@canberra.edu.au.
BMJ open
|March 4, 2026
概括
本项目协议概述了残疾人支持工作者 (DSWs) 关于在智力和发育残疾人中适当使用精神药物的培训计划. 该培训旨在加强DSW的培训能力.
科学领域:
- 智力和发育障碍 智力和发育障碍
- 心理药理学 心理药理学
- 医疗保健工作人员培训 医疗保健工作人员培训
背景情况:
- 对智力和发育障碍 (IDD) 个体的关注行为过度使用心理药物是一个重要的公共卫生问题.
- 残疾人支持工作者 (DSW) 在管理IDD成年人的精神药物治疗方面至关重要.
- 对于适当使用这些药物,有必要针对性地进行DSW培训.
研究的目的:
- 为DSW制定一个全面的培训计划,重点是对IDD患者适当使用精神药物.
- 为了提高DSW的知识,信心和技能,在管理心理药物和支持个人IDD.
主要方法:
- 一个参与式的行动框架和学习的通用设计方法将指导程序的开发.
- 联合制作涉及IDD患者,家庭,DSW,医疗保健专业人员和教育设计师.
- 关键步骤包括需求分析,文献审查,焦点小组,共同设计活动,现场测试,使用培训员模型进行可行性试验和混合方法过程评估.
主要成果:
- 预计这次培训将提高DSW对IDD患者适当精神药物处方的知识.
- 增强与医疗保健专业人员沟通的信心和非药物战略的应用.
- 促进共享决策,倡导药物审查和积极互动.
结论:
- 开发的培训计划旨在为DSW提供在IDD中适当的精神药物管理的基本技能.
- 该节目在澳大利亚各地的联合制作和传播,免费提供给DSW,确保了广泛的可访问性.
- 预计成功实施将对客户的结果产生积极影响,并为IDD患者提供支持.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
645
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
645
02:07Blind Procedures
13.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.8K
01:28Drug Therapy
346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
346